Tru Independence Asset Management 2 »

Brainstorm Cell Therapeutics shares owned by Tru Independence Asset Management 2

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Tru Independence Asset Management 2 from 13F filings

Historical chart of Tru Independence Asset Management 2 investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Tru Independence Asset Management 2 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Tru Independence Asset Management 2

Quarter filed Position value Share count Share price at filing
2024-09-30 $10k 44k 0.23
2023-03-31 $145k 44k 3.30
2022-09-30 $194k 44k 4.41

More positions owned by Tru Independence Asset Management 2

Dimensional Etf Trust Short Duration F (DFSD)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Ishares Tr Short Treas Bd (SHV)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Dimensional Etf Trust Inflation Prote (DFIP)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Dimensional Etf Trust Intl Small Cap V (DISV)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Amazon (AMZN)
Dimensional Etf Trust Internatnal Val (DFIV)
Ishares Tr 3 7 Yr Treas Bd (IEI)

View all positions for Tru Independence Asset Management 2

Top funds holding Brainstorm Cell Therapeutics

Armistice Capital
Vanguard Group
Geode Capital Management
BlackRock
BlackRock
Liberty Wealth Management
Weaver Consulting Group
Susquehanna International
State Street Corporation
Northern Trust
Two Sigma Securities
Raymond James & Associates
Tower Research Capital
Jmac Enterprises
Wells Fargo & Company

View all funds holding Brainstorm Cell Therapeutics